Raia Drogasil S.A.
RADLY
$4.54
-$0.04-0.87%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.24B | 2.07B | 1.91B | 1.72B | 1.73B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.24B | 2.07B | 1.91B | 1.72B | 1.73B |
| Cost of Revenue | 1.58B | 1.46B | 1.35B | 1.22B | 1.21B |
| Gross Profit | 660.12M | 608.91M | 564.86M | 492.55M | 512.29M |
| SG&A Expenses | 521.67M | 474.21M | 437.91M | 411.48M | 421.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 166.80K | -6.52M | -- |
| Total Operating Expenses | 2.10B | 1.93B | 1.78B | 1.63B | 1.64B |
| Operating Income | 138.45M | 134.70M | 126.78M | 87.59M | 90.39M |
| Income Before Tax | 56.14M | 100.00M | 70.57M | 34.23M | 48.27M |
| Income Tax Expenses | 2.34M | 15.22M | 3.00M | 6.03M | -11.65M |
| Earnings from Continuing Operations | 53.80M | 84.78M | 67.58M | 28.20M | 59.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.66M | -1.42M | -1.58M | -190.00K | 20.70K |
| Net Income | 56.46M | 83.37M | 66.00M | 28.01M | 59.94M |
| EBIT | 138.45M | 134.70M | 126.78M | 87.59M | 90.39M |
| EBITDA | 188.37M | 169.12M | 162.56M | 119.67M | 121.81M |
| EPS Basic | 0.04 | 0.05 | 0.04 | 0.02 | 0.04 |
| Normalized Basic EPS | 0.03 | 0.03 | 0.03 | 0.01 | 0.02 |
| EPS Diluted | 0.04 | 0.05 | 0.04 | 0.02 | 0.04 |
| Normalized Diluted EPS | 0.03 | 0.03 | 0.03 | 0.01 | 0.02 |
| Average Basic Shares Outstanding | 1.55B | 1.68B | 1.68B | 1.68B | 1.68B |
| Average Diluted Shares Outstanding | 1.55B | 1.69B | 1.69B | 1.69B | 1.68B |
| Dividend Per Share | 0.01 | 0.01 | 0.01 | 0.01 | -- |
| Payout Ratio | 112.92% | 0.02% | 82.42% | 0.06% | 67.32% |